Patrick Harrison Carroll - 06 Aug 2025 Form 4 Insider Report for Hims & Hers Health, Inc. (HIMS)

Role
Chief Medical Officer, Director
Signature
/s/ Alexandra Cotter Wilkins, Attorney-in-Fact
Issuer symbol
HIMS
Transactions as of
06 Aug 2025
Net transactions value
-$3,214,878
Form type
4
Filing time
08 Aug 2025, 16:19:36 UTC
Previous filing
16 Jun 2025
Next filing
17 Sep 2025
SEC
View on sec.gov

Reporting Owners (1)

Name Relationship Address Signature Signature date CIK
Carroll Patrick Harrison Chief Medical Officer, Director 2269 CHESTNUT STREET, #523, SAN FRANCISCO /s/ Alexandra Cotter Wilkins, Attorney-in-Fact 08 Aug 2025 0001839736

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction HIMS Class A Common Stock Sale $3,214,878 -60,000 -26% $53.58 169,940 06 Aug 2025 Direct F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction HIMS Restricted Stock Unit Award $0 +3,656 $0.000000 3,656 06 Aug 2025 Class A Common Stock 3,656 Direct F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Price reported constitutes the average weighted price of shares sold. Shares were sold at varying prices in the range of $53.19 - $53.97. The Reporting Person hereby undertakes, upon request of the Commission, the issuer or a security holder of the issuer, to provide full information regarding the number of shares sold at each separate price.
F2 The Reporting Person was granted Restricted Stock Units ("RSUs") which represent a contingent right to receive one share of Class A Common Stock for each RSU. Subject to continuous service, the RSUs will vest on the earlier of (a) the date of the 2026 annual meeting of stockholders or (b) June 15, 2026.